中文 | English
Return
Total: 1015 , 1/102
Show Home Prev Next End page: GO
Author:( Jia SU)

1.Relationship between vimentin and glucocorticoid-induced cataract

Jia-Jia, GE ; Sheng, SU ; Ping, LIU

International Eye Science 2014;(11):1975-1977

2. The case-control study of lung cancer in Taiyuan, China

Jia SU

Tumor 2013;33(10):884-890

3. Effect of denatured collagen type on endothelial cell proliferation, migration and angiogenesis-related proteins expression

Rong-Jia SU

Journal of Shanghai Jiaotong University(Medical Science) 2019;39(12):1348-1352

4.Progress in the study of dawn penomenon and extended dawn phenomenon in patients with diabetes

Hang SU ; Jian ZHOU ; Weiping JIA

Chinese Journal of Endocrinology and Metabolism 2015;(8):739-742

5.Rab13 regulates the distribution of occludin and F-actin at the blood-testis barrier via PKA activity in rats

Wenhui SU ; Xiaoyu JIA ; Xiaona MENG

Acta Laboratorium Animalis Scientia Sinica 2015;(4):359-364

6.Eosinophil could predict the prognosis of patients with bloodstream infection: a retrospective analysis of 305 cases

Duan GUO ; Chao JIA ; Hang SU

Chinese Critical Care Medicine 2017;29(6):496-500

7.Significance of combined detection of autoantibodies in systemic lupus erythematosus

Yin SU ; Rulin JIA ; Zhanguo LI

Chinese Journal of Rheumatology 2001;0(01):-

8.Expression of BCL-2 in MCF-7 cells: a mechanism for apoptosis antagonism and immune evasion in breast cancer cells

Fengxi SU ; Jisheng CHEN ; Weijuan JIA

Chinese Journal of General Surgery 2001;0(09):-

9.Sentinel lymph node biopsy for breast cancer: a result of 126 cases

Weijuan JIA ; Fengxi SU ; Jisheng CHEN

Chinese Journal of General Surgery 1993;0(03):-

10.Clinical effect of combination of clopidogrel and simvastatin on coronary heart disease complicated with transient ischemic attack

Hong LI ; Shilong JIA ; Xiancai SU

Clinical Medicine of China 2009;25(11):1149-1151

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1015 , 1/102 Show Home Prev Next End page: GO